Axcelis Tech Ord Stock Price, News & Analysis

Axcelis Technologies (NASDAQ: ACLS) reported its Q2 2025 financial results with revenue of $194.5 million, showing resilience despite market challenges. The company achieved a GAAP gross margin of 44.9% and non-GAAP gross margin of 45.2%, with GAAP diluted EPS of $0.98 and non-GAAP EPS of $1.13.

Notable highlights include increased share repurchase activity of $45 million during the quarter and strong profitability despite cyclical market digestion. For Q3 2025, Axcelis projects revenues of approximately $200 million with GAAP EPS of $0.87 and non-GAAP EPS of $1.00.

Axcelis Technologies (NASDAQ: ACLS), a leading provider of ion implantation solutions for the semiconductor industry, has announced its participation in three upcoming investor conferences in August 2025:

• KBCM Technology Leadership Forum - August 11th at Montage Deer Valley, Park City, UT
• Jefferies Semiconductor, IT Hardware and Communications Technology Conference - August 26th at Four Seasons Hotel, Chicago, IL
• Evercore ISI 2025 Semiconductor Conference - August 27th at Omni Chicago, IL

Axcelis Technologies (Nasdaq: ACLS), a leading semiconductor ion implantation solutions provider, has scheduled its Q2 2025 earnings release and conference call. The financial results will be released before market open on Tuesday, August 5, 2025, followed by a conference call at 8:30 a.m. ET the same day.

Investors can access the webcast through Axcelis' website investor section or by registering directly through the provided link. The webcast replay will remain available for 30 days after the call.

Axcelis Technologies (NASDAQ: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has announced its participation in eight major investor conferences between May and June 2025. The company will attend prestigious events including the J.P. Morgan Global Technology Conference, B. Riley Investor Conference, TD Cowen Technology Conference, Stifel Cross Sector Conference, William Blair Growth Stock Conference, Bank of America Global Technology Conference, and DA Davidson Consumer & Technology Conference.

At the William Blair conference, management will conduct a Fireside Chat at 2:00 PM Central Time on June 4th, which will be publicly accessible via webcast through Axcelis' website.

Axcelis Technologies (NASDAQ: ACLS) reported Q1 2025 financial results with revenue of $192.6 million, showing a decline from $252.4 million in Q1 2024. The company maintained strong margins with a GAAP gross margin of 46.1% and non-GAAP gross margin of 46.4%. Net income decreased to $28.6 million ($0.88 per diluted share) from $51.6 million ($1.57 per diluted share) year-over-year. For Q2 2025, Axcelis projects revenue of approximately $185 million with GAAP EPS of $0.57 and non-GAAP EPS of $0.73, indicating continued market challenges. Despite the revenue decline, the company maintains a strong financial position with no debt and continues share repurchases while investing in innovation.

Axcelis Technologies (NASDAQ: ACLS) announced its sponsorship and participation in the Advanced Semiconductor Manufacturing Conference (ASMC) scheduled for May 5-8, 2025, in Albany, New York. The company will present research on particle control for low-energy boron implantation in Session 5: Contamination Free Manufacturing.

Dr. Phillip Geissbuhler, Staff Scientist at Axcelis, will present findings from a collaborative study with SK Hynix on May 6, 2025. The presentation focuses on new hardware implementation that reduces particle contamination during low-energy boron implants by increasing ion beam angles to enhance self-sputtering of films. This innovation significantly reduces film buildup on surfaces near implanted wafers, addressing a critical yield-impacting issue in semiconductor manufacturing.

Axcelis Technologies (NASDAQ: ACLS) has issued a correction to their previous press release regarding their participation in the Advanced Semiconductor Manufacturing Conference (ASMC). The correction pertains to two coauthor names: Charlie Free (previously listed as David Free) and DaeYoon Kim (previously listed as Dae Yun Kim).

The company will sponsor ASMC, scheduled for May 5-8, 2025, at the Hilton Albany, New York. During Session 5: Contamination Free Manufacturing on May 6, Dr. Phillip Geissbuhler will present research on 'Particle Control for Low-Energy Boron Implantation' at 3:40 PM.

The presentation details a case study on reducing particle contamination during low-energy boron implants through new hardware implementation. The innovation increases ion beam angle to enhance self-sputtering of films, significantly reducing film buildup on surfaces near implanted wafers, thereby improving device yields.

Axcelis Technologies (Nasdaq: ACLS), a leading ion implantation solutions provider for the semiconductor industry, has scheduled its first quarter 2025 financial results announcement. The company will release its Q1 2025 results before market opening on Tuesday, May 6, 2025, followed by a conference call at 8:30 a.m. ET the same day.

Investors can access the earnings call via webcast through Axcelis' website investor section or by registering directly as participants. The webcast replay will remain available for 30 days after the call.

Axcelis Technologies (Nasdaq: ACLS) announced its participation as the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025, held alongside SEMICON China 2025 from March 25-27, 2025, at the Kerry Hotel in Pudong, Shanghai.

The company's President and CEO, Russell Low, will deliver a keynote speech titled 'Innovation in Ion Implantation for Power and Compound Semiconductor Devices' at 14:30 in Shanghai Ballroom 3. As a leading supplier of ion implantation solutions for the semiconductor industry, Axcelis aims to showcase its broad portfolio and technical expertise to Chinese chipmakers.